Baard, Joyce https://orcid.org/0000-0002-5509-0213
Cormio, Luigi https://orcid.org/0000-0001-6747-0179
Dasgupta, Ranan https://orcid.org/0000-0001-8044-8902
Maruzzi, Daniele https://orcid.org/0000-0002-1553-8060
Rais-Bahrami, Soroush https://orcid.org/0000-0001-9466-9925
Serrano, Alvaro https://orcid.org/0000-0002-2576-7959
Geavlete, Bogdan https://orcid.org/0000-0002-6156-1851
Giannakopoulos, Stilianos https://orcid.org/0000-0001-6173-8736
de la Rosette, Jean https://orcid.org/0000-0002-6308-1763
Laguna, Pilar https://orcid.org/0000-0003-0906-4417
Clinical trials referenced in this document:
Documents that mention this clinical trial
Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study
https://doi.org/10.1007/s00345-024-04866-w
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry
https://doi.org/10.1007/s00345-022-04168-z
Article History
Received: 4 October 2023
Accepted: 8 February 2024
First Online: 20 March 2024
Declarations
:
: Joyce Baard: Olympus, Boston Scientific, Coloplast, Urogen. Luigi Cormio, Ranan Dasgupta, Daniele Maruzzi, Alvaro Serrano, Bogdan Geavlete, Stilianos Giannakopoulos, Jean de la Rosette, Pilar Laguna: none. Soroush Rais-Bahrami: Intuitive Surgical, MDxHealth, Progenics, Tempus, Blue Earth Diagnostics, Bayer Healthcare, UroViu Corp.
: All the performed procedures were part of the routine care and in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: This is an observational study. Institutional review board approval was requested and was waived according to the Medical Research Involving Human Subjects Act (date of resolution: October 15, 2014; ref W14-273#14.17.329). Informed consent was not required, all information was pseudonymized and the submission does not include any images that may identify the participants.